Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1974
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: No OECD Guideline study but according to accepted scientific standards at time of performance, sufficiently documented and no unacceptable deviations

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974
Report date:
1974

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
no
Remarks:
Sufficient documentation to accept data
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Reference substance name:
Octopirox
IUPAC Name:
Octopirox
Constituent 2
Reference substance name:
Piroctone olamine
IUPAC Name:
Piroctone olamine
Constituent 3
Chemical structure
Reference substance name:
1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
EC Number:
272-574-2
EC Name:
1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
Cas Number:
68890-66-4
Molecular formula:
C14H23NO2.C2H7NO
IUPAC Name:
1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)
Constituent 4
Reference substance name:
1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone, 2-aminoethanol salt
IUPAC Name:
1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone, 2-aminoethanol salt

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 84 - 110 g
- Diet (e.g. ad libitum): Altromin 1324 ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: Yes


ENVIRONMENTAL CONDITIONS
- Temperature (°C):
- Humidity (%):
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):


IN-LIFE DATES: From: To:

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: sesame oil
Details on oral exposure:
- Concentration in vehicle: 25%
Doses:
4000 / 6300 / 7100 / 8000 / 9000 / 10000 / 15000 mg/kg body weight
No. of animals per sex per dose:
10
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations once daily / Weighing once weekly
- Necropsy of survivors performed: yes
Statistics:
Probit analysis

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
8 100 mg/kg bw
Mortality:
see table 1
Clinical signs:
other: disequilibrium, dyspnoe, convulsions
Gross pathology:
Dissection of rats killed at the end of the observation period revealed no macroscopic findings

Any other information on results incl. tables

Table 1: Mortality

 Dose (mg/kg body weight)  Mortality rate
 4000  0 / 10
 6300  0 / 10
 7100  1 / 10
 8000  7 / 10
 9000  6 / 10
 10000  10 / 10
 15000  10 / 10

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: expert judgment
Conclusions:
The median lethal dose of Piroctone Olamine (LD50) was 8100 (7660-8570) mg per kg body weight. Based on the result of this study Piroctone Olamine is not subject for labelling and classification requirements according to regulatory requirements
Executive summary:

The acute oral toxicity of Octopirox was investigated in rats using suspensions in sesame oil at a concentration of 25%. 10 female SPF-Wistar rats each were administered Octopirox by single-dose gavage at dose levels of 4000, 6300, 7100, 8000, 9000, 10000 or 15000 mg/kg body weight and were observed for 14 days. After application the animals showed the following symptoms: Disequilibrium, dyspnoe and convulsions. Gross pathology of lethally intoxictaed rats as well as of all rats at the end of the observation period revealed no remarkable macroscopic findings. The median lethal dose (LD50) was calculated to be 8100 mg/kg body weight.